AR067471A1 - A COMPONENT OF ANTI-PERTUSSIS VACCINE AND SIMPLIFIED PROCEDURE TO OBTAIN PERTACTIN (PRN) FROM BORDETELLA PERTUSSIS - Google Patents

A COMPONENT OF ANTI-PERTUSSIS VACCINE AND SIMPLIFIED PROCEDURE TO OBTAIN PERTACTIN (PRN) FROM BORDETELLA PERTUSSIS

Info

Publication number
AR067471A1
AR067471A1 ARP080102932A ARP080102932A AR067471A1 AR 067471 A1 AR067471 A1 AR 067471A1 AR P080102932 A ARP080102932 A AR P080102932A AR P080102932 A ARP080102932 A AR P080102932A AR 067471 A1 AR067471 A1 AR 067471A1
Authority
AR
Argentina
Prior art keywords
pertussis
prn
pertactin
vaccine
component
Prior art date
Application number
ARP080102932A
Other languages
Spanish (es)
Inventor
M L Mago
Rajesh Jain
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of AR067471A1 publication Critical patent/AR067471A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

Un componente de vacuna anti-pertusis obteniendo antígeno Pertactina (PRN) desde Bordetella pertussis. Un proceso simplificado para la extraccion y purificacion de Pertactina (PRN). La Pertactina obtenida por este procedimiento tiene un nivel de pureza mayor de 90% y el procedimiento usado en la presente previene la pérdida de PRN al evitar pasos complejos de procesamiento. La proteína de membrana externa (OMP) purificada por el procedimiento de la presente utiliza un proceso simplificado y es util en la preparacion de Vacunas Acelulares Anti-Pertussis, tanto sola como parte de combinaciones de vacunas. Reivindicacion 15: Un procedimiento para usar el componente de vacuna segun la reivindicacion 1, caracterizado porque comprende administrar a un sujeto necesitado de ello una cantidad del componente de vacuna.A component of anti-pertussis vaccine obtaining Pertactin antigen (PRN) from Bordetella pertussis. A simplified process for the extraction and purification of Pertactin (PRN). The Pertactin obtained by this procedure has a purity level greater than 90% and the procedure used herein prevents the loss of PRN by avoiding complex processing steps. The outer membrane protein (OMP) purified by the process herein uses a simplified process and is useful in the preparation of Anti-Pertussis Acellular Vaccines, both alone and as part of vaccine combinations. Claim 15: A method for using the vaccine component according to claim 1, characterized in that it comprises administering to a subject in need a quantity of the vaccine component.

ARP080102932A 2007-07-31 2008-07-07 A COMPONENT OF ANTI-PERTUSSIS VACCINE AND SIMPLIFIED PROCEDURE TO OBTAIN PERTACTIN (PRN) FROM BORDETELLA PERTUSSIS AR067471A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1618DE2007 2007-07-31

Publications (1)

Publication Number Publication Date
AR067471A1 true AR067471A1 (en) 2009-10-14

Family

ID=40303927

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102932A AR067471A1 (en) 2007-07-31 2008-07-07 A COMPONENT OF ANTI-PERTUSSIS VACCINE AND SIMPLIFIED PROCEDURE TO OBTAIN PERTACTIN (PRN) FROM BORDETELLA PERTUSSIS

Country Status (3)

Country Link
AR (1) AR067471A1 (en)
CL (1) CL2008002003A1 (en)
WO (1) WO2009016651A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010131111A1 (en) * 2009-05-11 2010-11-18 Novartis Ag Antigen purification process for pertactin antigen
US10329323B2 (en) * 2014-07-25 2019-06-25 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Method for purifying antibodies using PBS
KR102426041B1 (en) * 2017-08-01 2022-07-29 주식회사 녹십자 Method for obtaining bordetella pertussis related protein comprising processes of freezing and thawing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007657D0 (en) * 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
EP1762246A1 (en) * 1996-07-02 2007-03-14 Sanofi Pasteur Limited Multivalent DTP-Polio vaccines

Also Published As

Publication number Publication date
CL2008002003A1 (en) 2008-11-03
WO2009016651A1 (en) 2009-02-05

Similar Documents

Publication Publication Date Title
AR107020A2 (en) PCSK9 VACCINE (SUBTILISINE-KEXINA TYPE 9 CONVERTASE PROTEIN)
PE20100366A1 (en) NOVEL COMPOSITIONS OF VACCINE WITH CELLULAR WHOOUS COUGH AS WELL AS THE METHOD FOR ITS ELABORATION
EA200801221A1 (en) VIRAL VACCINES OBTAINED FROM CELLS WITH LOW LEVELS OF RESIDUAL CELL DNA
AR061152A1 (en) RECOMBINANT VACCINE AGAINST VIRUSES OF THE BLUE LANGUAGE
PE20080748A1 (en) VACCINE BASED ON THE NEISSERIA STRAINS
PE20140986A1 (en) FUSION PROTEINS AND COMBINATION VACCINES INCLUDING PROTEIN E AND PILIN A FROM HAEMOPHILUS INFLUENZAE
MX2019005137A (en) Vaccine against porcine parvovirus.
EA200900289A1 (en) VACCINE
EA201170493A1 (en) MICROORGANISMS AND VACCINES DEPENDING ON REPLICATION OF NON-NATURAL AMINO ACIDS
PE20190458A1 (en) NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS OF THE SAME
BR112013017171A2 (en) stable immunogenic combination vaccine, stable combination vaccine preparation process, method of using antigenic molecules and method of administration to human subjects
WO2022043551A8 (en) Multivalent nucleic acid based coronavirus vaccines
JP2009514840A5 (en)
WO2009152147A3 (en) Compositions and methods for dengue virus (dv) treatment and vaccination
PE20100365A1 (en) NEW COMBINATION VACCINES WITH WHOLE CELL COUGH AND METHOD FOR THEIR PREPARATION
EA201171032A1 (en) TREATMENT SCHEMES WITH THE HELP OF VACCINE AGAINST FLU, ASSOCIATED WITH PANDEMIC STRAINS
EA201391200A1 (en) METHODS AND COMPOSITIONS FOR VACCINATION FROM STAPHYLOCOCCUS AUREUS
PH12015501875A1 (en) Acellular pertussis vaccine
AR067471A1 (en) A COMPONENT OF ANTI-PERTUSSIS VACCINE AND SIMPLIFIED PROCEDURE TO OBTAIN PERTACTIN (PRN) FROM BORDETELLA PERTUSSIS
EP3492097A1 (en) Combination immunogenic compositions
CL2021003211A1 (en) A modified live strain of porcine reproductive and respiratory syndrome virus (prrs), a vaccine comprising it and its use to treat prrs type ii. (divisional application no. 2123-2018)
NZ738909A (en) Protease-resistant lipidated glp-1 analogs
PE20211648A1 (en) COMPOSITION OF COMBINED VACCINE INCLUDING REDUCED DOSES OF INACTIVATED POLIO VIRUS AND METHOD OF PREPARING IT
DE60336588D1 (en) IMPROVED ANTHRAXIMP AND METHOD OF DELIVERY
PH12019500404A1 (en) Multivalent vaccine composition

Legal Events

Date Code Title Description
FB Suspension of granting procedure